clofarabine has been researched along with forodesine in 4 studies
Studies (clofarabine) | Trials (clofarabine) | Recent Studies (post-2010) (clofarabine) | Studies (forodesine) | Trials (forodesine) | Recent Studies (post-2010) (forodesine) |
---|---|---|---|---|---|
424 | 101 | 280 | 109 | 7 | 27 |
Protein | Taxonomy | clofarabine (IC50) | forodesine (IC50) |
---|---|---|---|
Purine nucleoside phosphorylase | Homo sapiens (human) | 0.0518 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Larson, RA | 1 |
Korycka, A; Lech-MaraĆda, E; Robak, T | 1 |
Baleydier, F; Domenech, C; Thomas, X | 1 |
Le Jeune, C; Thomas, X | 1 |
4 review(s) available for clofarabine and forodesine
Article | Year |
---|---|
Three new drugs for acute lymphoblastic leukemia: nelarabine, clofarabine, and forodesine.
Topics: Adenine Nucleotides; Antineoplastic Agents; Apoptosis; Arabinonucleosides; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clofarabine; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones | 2007 |
Novel purine nucleoside analogues for hematological malignancies.
Topics: Adenine Nucleotides; Antineoplastic Agents; Arabinonucleosides; Clinical Trials as Topic; Clofarabine; Hematologic Neoplasms; Humans; Purine Nucleosides; Pyrimidinones | 2008 |
[Novel conventional therapies in onco-hemathology].
Topics: Adenine Nucleotides; Antibodies, Monoclonal; Antineoplastic Agents; Arabinonucleosides; Chemistry, Pharmaceutical; Clofarabine; Hematologic Neoplasms; Humans; Molecular Targeted Therapy; Purine Nucleosides; Pyrimidinones | 2011 |
Treating adults with acute lymphocytic leukemia: new pharmacotherapy options.
Topics: Adenine Nucleotides; Adult; Antibodies, Monoclonal; Antineoplastic Agents; Arabinonucleosides; Clofarabine; Disease-Free Survival; Drug Discovery; Humans; Molecular Targeted Therapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Purine Nucleosides; Pyrimidinones; Quality of Life; Recurrence; Salvage Therapy | 2016 |